Home/Filings/4/0001213900-19-018174
4//SEC Filing

Danenberg Noam 4

Accession 0001213900-19-018174

CIK 0001218683other

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 5:16 PM ET

Size

7.1 KB

Accession

0001213900-19-018174

Insider Transaction Report

Form 4
Period: 2019-06-30
Danenberg Noam
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2019-06-30+17,500142,500 total
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2019-06-3017,500122,500 total
    Common Stock (17,500 underlying)
Footnotes (2)
  • [F1]Each RSU represents a right to receive one share of Wize Pharma, Inc. common stock.
  • [F2]On March 31, 2019, the reporting person was granted 140,000 restricted stock units, vesting quarterly over a two-year period with the first installment issued on June 30, 2019.

Documents

1 file

Issuer

Wize Pharma, Inc.

CIK 0001218683

Entity typeother

Related Parties

1
  • filerCIK 0001720898

Filing Metadata

Form type
4
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 5:16 PM ET
Size
7.1 KB